Thrivent Financial For Lutherans 10x Genomics, Inc. Transaction History

Thrivent Financial For Lutherans

  • $51.6 Billion
  • Q4 2024

Shares

3 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q2 2023

Aug 14, 2023
BUY
$50.96 - $58.72 $805,626 - $928,304
15,809 Added 85.62%
34,273 $1.91 Million
Q4 2022

Feb 08, 2023
BUY
$24.4 - $41.3 $153,305 - $259,487
6,283 Added 51.58%
18,464 $673,000
Q3 2022

Nov 14, 2022
BUY
$28.48 - $52.59 $346,914 - $640,598
12,181 New
12,181 $347,000

Others Institutions Holding TXG

# of Institutions
293
Shares Held
98.2M
Call Options Held
263K
Put Options Held
85.1K
View Full List

About 10x Genomics, Inc.

TXG Quotes by TradingView
  • Ticker TXG
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Health Information Services
  • Shares Outstandng 95,046,400
  • Market Cap $1.35B
  • Description
  • 10x Genomics, Inc., a life science technology company, develops and sells instruments, consumables, and software for analyzing biological systems in North America, Europe, the Middle East, Africa, China, and the Asia Pacific. The company provides chromium and chromium connect instruments, microfluidic chips, slides, reagents, and other consumabl...
More about TXG
Track This Portfolio

Track Thrivent Financial For Lutherans Portfolio

Follow Thrivent Financial For Lutherans and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Thrivent Financial For Lutherans, based on Form 13F filings with the SEC.

News

Stay updated on Thrivent Financial For Lutherans with notifications on news.

Choose your preferred platform and Sign Up 👇 Telegram Email